LUMIRA VENTURES - Key Persons
Alice joined the Lumira Ventures as a full-time member in January 2022, following her successful experience of being selected in 2021 as part of the inaugural class of the Lumira Venture Innovation...
Job Titles:
- Member of the Operations Team
- Communications and Impact Specialist
Alyssia joined the Lumira Ventures team in September 2021 as a Junior Analyst. Prior to joining the team, Alyssia completed an honors BSc degree in biology, majoring in genetics from Western... Read More
Baye Galligan joined Lumira Ventures' Toronto office as an analyst in 2017. She focuses on business and technical due diligence and analyses of investment opportunities, as well as financial analysis... Read More
Baye Galligan joined Lumira Ventures' Toronto office as an analyst in 2017. She focuses on business and technical due diligence and analyses of investment opportunities, as well as financial analysis and proactive industry research.
Prior to joining Lumira, Baye was Research Manager at the National Angel Capital Organization and Associate Director of Maple Leaf Angels, the largest network of angel investors in Toronto, where she evaluated applications for early-stage investment, conducted due diligence, and organized community building initiatives. Baye holds a M.A. in organic chemistry from Harvard University, where she was an executive member of the Harvard Women in Chemistry. She also holds an HBA from the Richard Ivey School of Business and a B.Sc. in chemistry from Western University.
Dr. Norton joined the firm in 2016 as a Venture Partner based in Toronto, Ontario. In addition, he is engaged Board member of the Association of the Faculties of Medicine of Canada (AFMC), an advisor to several firms in the Local Toronto Life Sciences Ecosystem, and a member of the Research Committee for CAMH. Prior to joining Lumira, Dr. Norton has had roles as President, CEO, and Executive Director of multiple life science companies and held a variety of board-level positions.
With over 25 years of experience in the life sciences industry, Dr. Norton uses his cross-functional knowledge to develop strategy, raise capital and build important relationships in the academic and... Read More
Job Titles:
- Member of the Operations Team
- Accounting / Office Manager
- Key Member
With over 25 years of financial and office management experience, Dahlia is a key member of the operations team responsible for the day-to-day operational and financial administration of Lumira... Read More
An experienced senior executive with leading expertise in financing and corporate business development, Daniel located in Montréal spent 10 years at Shire Pharmaceuticals and at Biochem Pharma prior to its acquisition by Shire. As vice president, business development (North America) and vice president, corporate development, respectively, he led several financing, licensing and M&A transactions in the therapeutics, vaccine and diagnostics sectors. At Biochem, as well as serving on the company's portfolio committee and the steering committee of strategic research collaborations, Daniel served on the boards of investee companies. Prior to joining Biochem Pharma, Daniel was an investment banker at a major Canadian Investment Bank where he was involved in M&A and financing transactions across various industrial sectors.
With over 20 years of investment banking, corporate development, and licensing and investment experience, Daniel has been involved with life sciences companies at all stages of development in North... Read More
David Novak joined the Lumira team in 2022 as a venture partner with a focus on developing public market investment strategies that leverage and build on the Lumira franchise. Mr. Novak brings to... Read More
David Novak joined the Lumira team in 2022 as a venture partner with a focus on developing public market investment strategies that leverage and build on the Lumira franchise. Mr. Novak brings to Lumira Ventures extensive capital markets, industry, and clinical research experience having served as a managing director at Raymond James, a large global investment dealer, where he covered the North American Biotechnology equities. In 2020, Mr. Novak was nominated as a "top 40 under 40" candidate by the Investment Industry of Canada. Additionally, he has been a leading source of biotechnology insight, appearing on CNBC, BNN/Bloomberg, CBC, and in various written media formats.
Before making his mark as a research analyst, Mr. Novak spent a number of years working on the scientific research side of the biotechnology industry, developing molecular diagnostic tests for oncology indications at a publicly-held company. Mr. Novak has additionally served as a clinical research scientist investigating both the hereditary predisposition to cancer as well as the experimental therapeutics which treat such cancers. His research has since culminated in multiple, high-impact publications within journals such as the New England Journal of Medicine.
David holds a Master of Science (Human Medical Genetics) from McGill University.
Dr. Richard M. Glickman is one of Canada's best known and most successful healthcare entrepreneurs. He is a co-founder and the chairman of Aurinia Pharma Corp., the founding Chairman of the Board of Essa Pharmaceuticals Inc., and is Chairman of the Board of Engene Inc. Previous roles include; co-founder, Chairman and CEO of Aspreva Pharmaceuticals and co-founder and CEO of StressGen Biotechnologies Corporation. Dr. Glickman also serves on the Boards of Vigil Health Solutions Inc and Cardiome Pharma Corp.
In addition to his corporate roles Richards has served on numerous biotechnology and community boards including Life Sciences B.C., the Canadian Genetic Disease Network, and the federal government's National Biotechnology Advisory Committee. In 2004, Richard received the Ernst & Young Entrepreneur of the Year Award and British Columbia's Top 40 under 40 Award for Entrepreneurs.
Dr. Glickman holds a B.Sc. in Microbiology and Immunology from the McGill University.
Dr. Richard M. Glickman is one of Canada's best known and most successful healthcare entrepreneurs. He is a co-founder and the chairman of Aurinia Pharma Corp., the founding Chairman of the Board... Read More
Job Titles:
- Managing Director
- Member of the Investment Team
With over 28 years of investment, consulting and entrepreneurial experience in the health care industry, Gerry has helped build life sciences companies at all stages of development. He focuses on... Read More
With over 20 years of life science, IT and business development executive-level experience, Jacki is a key member of the senior investment team sourcing, conducting diligence on, structuring deals... Read More
Lu is passionate about helping entrepreneurs achieving their goals being a co-founder of a start-up company prior to joining Lumira Ventures in late 2014 as an analyst and later promoted to Director... Read More
Job Titles:
- Controller
- Member of the Operations Team
Michael joined Lumira Ventures in August 2022; as Controller, Michael will focus on the finance, legal, and operations of the Lumira investment funds. He will continue to enhance the implementation... Read More
Nikhil joined Lumira Ventures in March 2019. Having spent his entire career in the healthcare industry, he is keen to use his broad expertise to help inventors and entrepreneurs bring clinically meaningful treatments to patients in need. As Principal, Nikhil will focus on business development, investment due diligence and technical analysis including forecasting and financial modeling.
Job Titles:
- Managing General Partner
- Member of the Investment Team
With 28 years of investment and operating experience, Peter has participated in building companies from start-up through to expansion in the life sciences, information technology, and consumer... Read More
Suman comes from a strong life science background, with special expertise in oncology and developing multi-targeted strategies to treat advanced cancers. Suman joined Lumira in 2021 as an Associate... Read More
Dr. Witek served Boehringer Ingelheim Pharmaceuticals for nearly 25 years where he held various pharmacology and clinical research positions, including Director of Respiratory and Immunology Clinical... Read More
Job Titles:
- CFO
- Member of the Operations Team
- Key Member of Senior Management Working Closely
Contributing over 20 years of senior financial management and audit experience, Vasco is a key member of senior management working closely with our investment team, external auditors and other... Read More